FTC review | GenomeWeb

FTC review

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific announced after the close of the market on Wednesday a public offering of $2.2 billion of its common stock.

NEW YORK (GenomeWeb News) – The US Federal Trade Commission has made a second request to Complete Genomics and BGI-Shenzhen requesting additional information about BGI's proposed $117.6 million purchase of

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Laboratory Corporation of America today said it has extended its cash tender offer to purchase Orchid Cellmark to 5 p.m. EDT Oct. 7.

LabCorp extended the offer for 30 days while the FTC continues its review of the $85.4 million acquisition.

As of May 17, Orchid shareholders had tendered and not withdrawn about 85 percent of the company's outstanding shares.

The FTC provided provisional approval of Danaher's purchase of MDS Analytical Technologies. However, it is requiring MDS to sell its laser microdissection business to Life Technologies to alleviate the agency's competition concerns.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.